RetractedArticleComputational and mathematical methods in medicine2022

Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer.

Xiaolei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.